v3.25.2
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-In Capital
Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   169,867,414      
Beginning balance at Dec. 31, 2023 $ 106,018 $ 1,349,821 $ 81,270 $ (1,276,652) $ (48,421)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 2,014   2,014    
Issuance of common shares pursuant to the Open Market Sale Agreement (in shares)   8,666,077      
Issuance of common shares pursuant to the Open Market Sale Agreement 21,765 $ 21,765      
Issuance of common shares pursuant to exercise of options (in shares)   1,126,691      
Issuance of common shares pursuant to ESPP 2,454 $ 4,268 (1,814)    
Issuance of common shares pursuant to ESPP (in shares)   121,563      
Issuance of common shares pursuant to ESPP 211 $ 271 (60)    
Issuance of common shares upon vesting of RSUs   410,482      
Issuance of common shares upon vesting of RSUs 0 $ 1,190 (1,190)    
Unrealized loss on available-for-sale securities 50       50
Net loss (17,875)     (17,875)  
Ending balance (in shares) at Mar. 31, 2024   180,192,227      
Ending balance at Mar. 31, 2024 114,637 $ 1,377,315 80,220 (1,294,527) (48,371)
Beginning balance (in shares) at Dec. 31, 2023   169,867,414      
Beginning balance at Dec. 31, 2023 106,018 $ 1,349,821 81,270 (1,276,652) (48,421)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (37,671)        
Ending balance (in shares) at Jun. 30, 2024   188,739,044      
Ending balance at Jun. 30, 2024 122,454 $ 1,403,334 81,751 (1,314,323) (48,308)
Beginning balance (in shares) at Mar. 31, 2024   180,192,227      
Beginning balance at Mar. 31, 2024 114,637 $ 1,377,315 80,220 (1,294,527) (48,371)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 3,180   3,180    
Issuance of common shares pursuant to the Open Market Sale Agreement (in shares)   7,833,922      
Issuance of common shares pursuant to the Open Market Sale Agreement 22,359 $ 22,359      
Issuance of common shares pursuant to exercise of options (in shares)   712,895      
Issuance of common shares pursuant to ESPP 2,011 $ 3,660 (1,649)    
Unrealized loss on available-for-sale securities 63       63
Net loss (19,796)     (19,796)  
Ending balance (in shares) at Jun. 30, 2024   188,739,044      
Ending balance at Jun. 30, 2024 $ 122,454 $ 1,403,334 81,751 (1,314,323) (48,308)
Beginning balance (in shares) at Dec. 31, 2024 189,963,492 189,963,492      
Beginning balance at Dec. 31, 2024 $ 97,366 $ 1,410,025 82,048 (1,346,572) (48,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 3,564   3,564    
Issuance of common shares pursuant to exercise of options (in shares)   892,857      
Issuance of common shares pursuant to ESPP 2,653 $ 4,616 (1,963)    
Issuance of common shares pursuant to ESPP (in shares)   44,541      
Issuance of common shares pursuant to ESPP 131 $ 173 (42)    
Issuance of common shares upon vesting of RSUs   580,584      
Issuance of common shares upon vesting of RSUs 0 $ 1,518 (1,518)    
Unrealized loss on available-for-sale securities (31)       (31)
Net loss (24,526)     (24,526)  
Ending balance (in shares) at Mar. 31, 2025   191,481,474      
Ending balance at Mar. 31, 2025 $ 79,157 $ 1,416,332 82,089 (1,371,098) (48,166)
Beginning balance (in shares) at Dec. 31, 2024 189,963,492 189,963,492      
Beginning balance at Dec. 31, 2024 $ 97,366 $ 1,410,025 82,048 (1,346,572) (48,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (22,003)        
Ending balance (in shares) at Jun. 30, 2025 191,641,511 191,641,511      
Ending balance at Jun. 30, 2025 $ 82,976 $ 1,417,110 82,628 (1,368,575) (48,187)
Beginning balance (in shares) at Mar. 31, 2025   191,481,474      
Beginning balance at Mar. 31, 2025 79,157 $ 1,416,332 82,089 (1,371,098) (48,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 864   864    
Issuance of common shares pursuant to exercise of options (in shares)   160,037      
Issuance of common shares pursuant to ESPP 453 $ 778 (325)    
Unrealized loss on available-for-sale securities (21)       (21)
Net loss $ 2,523     2,523  
Ending balance (in shares) at Jun. 30, 2025 191,641,511 191,641,511      
Ending balance at Jun. 30, 2025 $ 82,976 $ 1,417,110 $ 82,628 $ (1,368,575) $ (48,187)